Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".

Nasser, Y

Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher". [electronic resource] - Neurogastroenterology and motility Apr 2014 - 447-54 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment

1365-2982

10.1111/nmo.12329 doi


Amidohydrolases--antagonists & inhibitors
Analgesics--pharmacology
Animals
Antidiarrheals--pharmacology
Endocannabinoids--metabolism
Gastrointestinal Motility--drug effects
Male
Receptor, Cannabinoid, CB1--metabolism